PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1944428
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1944428
Long-acting injectables (LAIs) Market, By Product Type, By Route of Administration, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
Long-acting injectables (LAIs) Market size was valued at USD 16,860.30 Million in 2024, expanding to a CAGR of 13.01% from 2025 to 2032.
A Long-acting injectables (LAIs) is a robotic end-of-arm device designed to pick, secure, and release objects by using electric motors rather than pneumatic or hydraulic systems. It is widely integrated with industrial robots, collaborative robots, and automated equipment for accurate and reliable material handling. These grippers function using servo or stepper motors that precisely control the movement of fingers or jaws, enabling adjustable gripping force, speed, and positioning. This precise control delivers high repeatability and accuracy, making Long-acting injectables (LAIs)s well suited for handling fragile, small, or irregularly shaped components.
Long-acting injectables (LAIs) Market- Market Dynamics
Improved medication adherence along with high prevalence of chronic disorders is anticipated to propel market demand
Long-acting injectables (LAIs) have the ability to significantly enhance medication adherence compared with daily oral treatments, boosting LAIs market growth. Chronic conditions, particularly psychiatric disorders such as schizophrenia and bipolar disorder, often face high rates of non-adherence, leading to disease relapse, frequent hospitalizations, and increased healthcare costs. LAIs provide a sustained release of medication over several weeks or months, eliminating the need for daily dosing and maintaining steady therapeutic levels in the body. This streamlined approach not only simplifies treatment routines but also reduces relapse risk, decreases hospital admissions, and alleviates the overall burden on healthcare systems. The reduced frequency of injections improves patient convenience, supports better long-term disease management, and makes LAIs an increasingly preferred option for both healthcare providers and patients.
Moreover, the rising prevalence of chronic and long-term health conditions, including psychiatric disorders, HIV/AIDS, diabetes, and hormonal imbalances also contributing to market demand. As global populations age and lifestyle-related illnesses become increasingly widespread, the need for therapies that provide continuous and reliable treatment is growing rapidly. LAIs are particularly advantageous in managing conditions where maintaining consistent drug levels is essential and where daily oral adherence is often difficult, such as in mental health or chronic infectious diseases. By offering sustained drug release over weeks or months, LAIs help mitigate the risks associated with missed doses, including disease progression and hospitalization. Moreover, the growing number of patients affected by these chronic conditions significantly expands the potential market for LAIs, driving strong demand across both developed and emerging regions. This trend is further reinforced by healthcare providers' preference for solutions that improve patient outcomes, reduce the burden on medical infrastructure, and promote long-term disease management.
Long-acting injectables (LAIs) Market- Segmentation Analysis:
The Global Long-acting injectables (LAIs) Market is segmented on the basis of Product Type, Route of Administration, Application, End User, and Region.
The market is divided into four categories based on Product Type: antipsychotics, hormonal agents, anti-infectives, and others. Antipsychotics segment hold major share in 2024. These formulations are primarily used to treat schizophrenia, bipolar disorder, and other chronic psychiatric conditions. Long-acting antipsychotics provide steady therapeutic drug levels over weeks or months, reducing the risk of relapse and minimizing side effects associated with fluctuating drug levels.
The market is divided into five categories based on Application: psychiatric disorders, HIV/AIDS, pain & chronic diseases, endocrine disorders, and others. Psychiatric disorders segment leads the LAI market due to the combination of large patient populations, chronic nature of illnesses, adherence challenges with oral medications, and strong clinical benefits of long-acting therapy. LAIs reduce relapse rates, hospital admissions, and the overall burden on healthcare systems. They provide predictable, consistent treatment, which is particularly important in severe psychiatric disorders where missed doses can have serious consequences.
Long-acting injectables (LAIs) Market- Geographical Insights
North America currently leads the Long-Acting Injectables (LAIs) market, driven by the widespread adoption of LAIs in psychiatric care, strong and well-established healthcare infrastructure, comprehensive insurance coverage, and early access to innovative therapies. The United States is the dominant contributor within the region, benefiting from increasing awareness among healthcare providers and patients about the advantages of LAIs in improving treatment adherence, reducing relapse rates, and optimizing long-term disease management. Continuous product launches and the availability of newer, more convenient formulations further strengthen the U.S. market. Europe holds the second-largest market share, with countries such as Germany, France, and the United Kingdom leading in adoption. The region's growth is supported by structured mental health programs, rising incidence of chronic psychiatric and endocrine disorders, and increasing demand for long-acting hormonal therapies.
United States- Long-acting injectables (LAIs) Market- Key Insights
The United States region growth is fueled by widespread use in psychiatric care, a strong healthcare infrastructure, and comprehensive insurance coverage. Millions of Americans are affected by chronic psychiatric disorders, such as schizophrenia and bipolar disorder, creating substantial demand for treatments that enhance medication adherence and reduce the risk of relapse. LAIs deliver medication gradually over weeks or months, maintaining stable therapeutic levels, minimizing hospitalizations, and supporting effective long-term disease management. Market growth is further driven by ongoing product innovation, including newer antipsychotic formulations with extended dosing intervals, improved tolerability, and more convenient modes of administration. Increased awareness among healthcare professionals and patients about the clinical advantages and cost-effectiveness of LAIs also accelerates adoption.
Long-acting injectables (LAIs) Market- Competitive Landscape:
The Long-Acting Injectables (LAIs) market in 2025 is moderately competitive, driven by leading global pharmaceutical companies that prioritize product innovation, therapeutic expansion, and strategic market launches. Johnson & Johnson, Pfizer continues to hold major revenue shares, offering a comprehensive portfolio of LAIs across psychiatric and oncology indications. The company's focus on enhancing patient adherence through robust support programs, educational initiatives, and convenient dosing schedules strengthens its market leadership and ensures consistent revenue growth. Both companies are setting benchmarks for innovation, while ongoing competition drives accelerated development of novel delivery technologies and patient-centric solutions, making the LAI sector one of the most dynamic segments in pharmaceuticals today.
Recent Developments:
In 2025, Lupin obtained U.S. FDA approval for its risperidone long-acting injectable, which also received 180-day Competitive Generic Therapy (CGT) exclusivity. This formulation is the first product developed under Lupin's PrecisionSphere LAI technology platform, showcasing the company's innovation in sustained-release injectable therapies.
In December 2025, Teva Pharmaceuticals filed a New Drug Application (NDA) with the U.S. FDA for its olanzapine extended-release injectable suspension (TEV-749), designed as a once-monthly therapy for adults living with schizophrenia.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET KEY PLAYERS
- Johnson & Johnson
- Pfizer
- Eli Lilly
- ViiV Healthcare
- Teva Pharmaceuticals
- Alkermes
- Lupin Limited
- Amneal Pharmaceuticals
- Sanofi
- Novartis
- Bristol-Myers Squibb
- GlaxoSmithKline (GSK)
- AbbVie
- Roche
- Sun Pharmaceutical Industries
- Others
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032
- Antipsychotics
- Hormonal agents
- Anti-infectives
- Others
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019-2032
- Intramuscular
- Intravenous (IV)
- Subcutaneous
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032
- Psychiatric disorders
- HIV/AIDS
- Pain & chronic diseases
- Endocrine disorders
- Others
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY END USER- MARKET ANALYSIS, 2019-2032
- Hospitals
- Clinics & Specialty Centers
- Others
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Long-acting injectables (LAIs) Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Long-acting injectables (LAIs) Market Snippet by Product Type
- 2.1.2. Long-acting injectables (LAIs) Market Snippet by Route of Administration
- 2.1.3. Long-acting injectables (LAIs) Market Snippet by Application
- 2.1.4. Long-acting injectables (LAIs) Market Snippet by End User
- 2.1.5. Long-acting injectables (LAIs) Market Snippet by Country
- 2.1.6. Long-acting injectables (LAIs) Market Snippet by Region
- 2.2. Competitive Insights
3. Long-acting injectables (LAIs) Key Market Trends
- 3.1. Long-acting injectables (LAIs) Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Long-acting injectables (LAIs) Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Long-acting injectables (LAIs) Market Opportunities
- 3.4. Long-acting injectables (LAIs) Market Future Trends
4. Long-acting injectables (LAIs) Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Long-acting injectables (LAIs) Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Long-acting injectables (LAIs) Market Landscape
- 6.1. Long-acting injectables (LAIs) Market Share Analysis, 2024
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Long-acting injectables (LAIs) Market - By Product Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. Antipsychotics
- 7.1.3. Hormonal agents
- 7.1.4. Anti-infectives
- 7.1.5. Others
8. Long-acting injectables (LAIs) Market - By Route of Administration
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
- 8.1.2. Intramuscular
- 8.1.3. Intravenous (IV)
- 8.1.4. Subcutaneous
9. Long-acting injectables (LAIs) Market - By Application
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 9.1.2. Psychiatric disorders
- 9.1.3. HIV/AIDS
- 9.1.4. Pain & chronic diseases
- 9.1.5. Endocrine disorders
- 9.1.6. Others
10. Long-acting injectables (LAIs) Market - By End User
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
- 10.1.2. Hospitals
- 10.1.3. Clinics & Specialty Centers
- 10.1.4. Others
11. Long-acting injectables (LAIs) Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Long-acting injectables (LAIs) Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Long-acting injectables (LAIs) Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.9. UK
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.9.4. UK Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.10. France
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.10.4. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.11.4. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
- 11.3.12.1. Overview
- 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.12.4. Spain Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
- 11.3.13.1. Overview
- 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.13.4. The Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Overview
- 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
- 11.3.15.1. Overview
- 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.15.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
- 11.3.17.1. Overview
- 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.17.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Long-acting injectables (LAIs) Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.8. China
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.8.4. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.9. India
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.9.4. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.14.4. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Long-acting injectables (LAIs) Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Long-acting injectables (LAIs) Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Long-acting injectables (LAIs) Industry
- 12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
- 12.2. Company Profiles
- 12.2.1. Johnson & Johnson
- 12.2.2. Pfizer
- 12.2.3. Eli Lilly
- 12.2.4. ViiV Healthcare
- 12.2.5. Teva Pharmaceuticals
- 12.2.6. Alkermes
- 12.2.7. Lupin Limited
- 12.2.8. Amneal Pharmaceuticals
- 12.2.9. Sanofi
- 12.2.10. Novartis
- 12.2.11. Bristol-Myers Squibb
- 12.2.12. GlaxoSmithKline (GSK)
- 12.2.13. AbbVie
- 12.2.14. Roche
- 12.2.15. Sun Pharmaceutical Industries
- 12.2.16. Others
13. 360 Degree Analyst View
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
